Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actemra in relapsing polychondritis
NCT01104480Phase 2Withdrawn
- Sponsor
- McMaster Children's Hospital
- Start
- May 2010
- Primary completion
- Jul 2010
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in relapsing polychondritis (RP), sponsored by McMaster Children's Hospital. Planned start May 2010; status: withdrawn.
02
Drugs
tocilizumab
03
Conditions
relapsing polychondritis (RP)
Beyond the preview
Go deeper on NCT01104480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104480.